BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 813284)

  • 1. Reduction in infarct size following experimental coronary occlusion by administration of verapamil.
    Singh BN; Smith HJ; Norris RM
    Recent Adv Stud Cardiac Struct Metab; 1975; 10():435-52. PubMed ID: 813284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of verapamil on infarct size following experimental coronary occlusion.
    Smith HJ; Singh BN; Nisbet HD; Norris RM
    Cardiovasc Res; 1975 Jul; 9(4):569-78. PubMed ID: 1182734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of verapamil on experimental myocardial ischaemia with a particular reference to regional myocardial blood flow and metabolism.
    Smith HJ; Singh BN; Norris RM; Nisbet HD; John MB; Hurley PJ
    Aust N Z J Med; 1977 Apr; 7(2):114-21. PubMed ID: 268165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of canrenoate potassium (aldactone pro injections) on hemodynamics and myocardial ischemia in experimental myocardial infarct].
    Kötter V; Leitner Ev; Arbeiter G; Cordes R; Schröder R
    Z Kardiol; 1975 Jul; 64(7):672-86. PubMed ID: 1163092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitroglycerin and dipyridamole on cardiac metabolism and dynamics in a new experimental model of angina pectoris.
    Szekeres L; Csik V; Udvary E
    J Pharmacol Exp Ther; 1976 Jan; 196(1):15-28. PubMed ID: 812980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thoracic epidural anesthesia reduces myocardial infarct size after coronary artery occlusion in dogs.
    Davis RF; DeBoer LW; Maroko PR
    Anesth Analg; 1986 Jul; 65(7):711-7. PubMed ID: 3717611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of verapamil and nitroglycerin on coronary and systemic hemodynamics in conscious dogs.
    Adachi H; Tomoike H; Nishijima H; Hayashi Y; Yamada A; Nakamura M
    J Pharmacol Exp Ther; 1987 Jun; 241(3):1072-8. PubMed ID: 3110406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of verapamil on coronary hemodynamics in patients with coronary heart disease.
    Simonsen S
    Eur J Cardiol; 1978 Aug; 8(1):9-18. PubMed ID: 689073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verapamil in two reperfusion models of myocardial infarction. Temporary protection of severely ischemic myocardium without limitation of ultimate infarct size.
    Reimer KA; Jennings RB
    Lab Invest; 1984 Dec; 51(6):655-66. PubMed ID: 6503220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative effects of nitroglycerin and nitroprusside during experimental acute myocardial ischemia.
    Pearlman AS; Engler RL; Goldstein RA; Kent KM; Epstein SE
    Eur J Cardiol; 1980; 11(4):295-313. PubMed ID: 6771145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemic changes in the canine heart as affected by the dimethyl quaternary analog of propranolol, UM-272 (SC-27761).
    Lucchesi BR; Burmeister WE; Lomas TE; Abrams GD
    J Pharmacol Exp Ther; 1976 Nov; 199(2):310-28. PubMed ID: 978488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limitation of infarct size for 24 hours by combined treatment with allopurinol plus verapamil during acute myocardial infarction in the dog.
    Kingma JG; Denniss AR; Hearse DJ; Downey JM; Yellon DM
    Circulation; 1987 Jun; 75(6 Pt 2):V25-33. PubMed ID: 3568337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoactive parathyroid hormone in the treatment of acute ischemic left ventricular failure and the prevention of cardiogenic shock.
    Feola M; Gonzales H; Canizaro PC
    Circ Shock; 1985; 17(2):163-77. PubMed ID: 4053300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-diabetic drug miglitol is protective against anginal ischaemia through a mechanism independent of regional myocardial blood flow in the dog.
    Uno Y; Minatoguchi S; Arai M; Wang N; Chen XH; Hashimoto K; Lu C; Takemura G; Fujiwara H
    Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):805-10. PubMed ID: 16173940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of perhexiline on survival time and infarct size in experimental myocardial infarction.
    Daniell HB; Privitera PJ; Conradi SE; Gaffney TE
    J Pharmacol Exp Ther; 1977 Jan; 200(1):155-65. PubMed ID: 833755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of the new calcium antagonist benidipine hydrochloride on myocardial dysfunction following coronary occlusion and reperfusion in anesthetized dogs.
    Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1717-21. PubMed ID: 3219147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Underlying mechanism of favorable effect of Ca++-antagonists on conduction delay observed in ischemic myocardium (author's transl)].
    Nakaya H
    Hokkaido Igaku Zasshi; 1981 May; 56(3):335-45. PubMed ID: 7319455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Isoproterenol induces ST-segment elevation without wall motion aggravation and myocardial ischemia in experimental myocardial infarction].
    Yamamoto T; Katori R
    J Cardiol; 1995 Sep; 26(3):167-75. PubMed ID: 7473047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nitroglycerin and dipyridamole on regional left ventricular blood flow during coronary artery occlusion.
    Becker LC
    J Clin Invest; 1976 Dec; 58(6):1287-96. PubMed ID: 825534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between epicardial ST-segment elevation and myocardial ischemic damage after experimental coronary artery occlusion in dogs.
    Heng MK; Singh BN; Norris RM; John MB; Elliot R
    J Clin Invest; 1976 Dec; 58(6):1317-26. PubMed ID: 993347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.